About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 412 record(s)
Req # A-2020-000879
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-106577-364, Deputy Ministerial meeting with Genome Canada.Organization: Health Canada
April 2021
Req # A-2020-000929
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111425-907.Organization: Health Canada
April 2021
Req # A-2020-000968
Adverse Reaction Reports (AERs). Report numbers: E2B_01678513, E2B_03248420, E2B_02121844, E2B_03233687, E2B_03233686, E2B_03234927, E2B_03234929.Organization: Health Canada
April 2021
Req # A-2020-001008
Adverse Drug Reaction (ADR) for DOCETAXEL. Report number: E2B_02874464.Organization: Health Canada
April 2021
Req # A-2020-001011
Adverse Reaction Reports (AERs). Report numbers: 000717171, 000727005, E2B_02967485, E2B_01713673, E2B_01810836, 000715549, 000715851, 000715871, 000715873, 000715874.Organization: Health Canada
April 2021
Req # A-2020-001012
Adverse Reaction Reports (AERs). Report numbers: E2B_02774304, 000729472, E2B_03183710, E2B_0938645, E2B_03143874, 000911144, E2B_03198032, E2B_03136579, E2B_02277706, E2B_03399486, E2B_03334724.Organization: Health Canada
April 2021
Req # A-2020-001038
Adverse Reaction Reports (AERs). Report numbers: 000722436, 000722438, 000722439, 000722442, 000722444, 000722446, 000722448, 000722450, 000722452, 000722455, 000722460, 000722461, 000722463, 000722465, 000722466, 000722474, 000722476, 000722478,…Organization: Health Canada
April 2021
Req # A-2020-001039
Adverse Reaction Reports (AERs). Report numbers: E2B_03175996, E2B_03184922, E2B_03186046, E2B_03186047.Organization: Health Canada
April 2021
Req # A-2020-001056
Adverse Reaction Reports (AERs). Report numbers: 000726511, 000726512, 000726514, 000726518, 000726520, 000726521, 000726526, 000726527, 000726528, 000726530, 000726532, 000726555, 000726558, 000726560, 000726562, 000726565, 000726568, 000726572,…Organization: Health Canada
April 2021
Req # A-2020-001094
Adverse Reaction Reports (AERs). Report numbers: 000730734, 000730742, 000730743, 000730937, 000731638, 000732487, 000734832, 000736479, 000736576, 000736587, 000737568, 000737943, 000908509, 000909174, 000910387, 000911001, 000911604, 000912897,…Organization: Health Canada
April 2021